Ether lipids from archaeas in nano-drug delivery and vaccination
- PMID: 36690132
- DOI: 10.1016/j.ijpharm.2023.122632
Ether lipids from archaeas in nano-drug delivery and vaccination
Abstract
Archaea are microorganisms more closely related to eukaryotes than bacteria. Almost 50 years after being defined as a new domain of life on earth, new species continue to be discovered and their phylogeny organized. The study of the relationship between their genetics and metabolism and some of their extreme habitats has even positioned them as a model of extraterrestrial life forms. Archaea, however, are deeply connected to the life of our planet: they can be found in arid, acidic, warm areas; on most of the earth's surface, which is cold (below 5 °C), playing a prominent role in the cycles of organic materials on a global scale and they are even part of our microbiota. The constituent materials of these microorganisms differ radically from those produced by eukaryotes and bacteria, and the nanoparticles that can be manufactured using their ether lipids as building blocks exhibit unique properties that are of interest in nanomedicine. Here, we present for the first time a complete overview of the pre-clinical applications of nanomedicines based on ether archaea lipids, focused on drug delivery and adjuvancy over the last 25 years, along with a discussion on their pros, cons and their future industrial implementation.
Keywords: Adjuvants; Archaeosomes; Drug delivery.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.Crit Rev Biotechnol. 1999;19(4):317-57. doi: 10.1080/0738-859991229170. Crit Rev Biotechnol. 1999. PMID: 10723627 Review.
-
Archaeosomes: New Generation of Liposomes Based on Archaeal Lipids for Drug Delivery and Biomedical Applications.ACS Omega. 2022 Dec 28;8(1):1-9. doi: 10.1021/acsomega.2c06034. eCollection 2023 Jan 10. ACS Omega. 2022. PMID: 36643444 Free PMC article. Review.
-
Archaeal ether lipids improve internalization and transfection with mRNA lipid nanoparticles.Eur J Pharm Biopharm. 2024 Apr;197:114213. doi: 10.1016/j.ejpb.2024.114213. Epub 2024 Feb 10. Eur J Pharm Biopharm. 2024. PMID: 38346479
-
New generation of liposomes called archaeosomes based on natural or synthetic archaeal lipids as innovative formulations for drug delivery.Recent Pat Drug Deliv Formul. 2009 Nov;3(3):206-20. doi: 10.2174/187221109789105630. Recent Pat Drug Deliv Formul. 2009. PMID: 19534669 Review.
-
Dominance of mixed ether/ester, intact polar membrane lipids in five species of the order Rubrobacterales: Another group of bacteria not obeying the "lipid divide".Syst Appl Microbiol. 2023 Apr;46(2):126404. doi: 10.1016/j.syapm.2023.126404. Epub 2023 Feb 24. Syst Appl Microbiol. 2023. PMID: 36868099
Cited by
-
Tetraether archaeal lipids promote long-term survival in extreme conditions.Mol Microbiol. 2024 May;121(5):882-894. doi: 10.1111/mmi.15240. Epub 2024 Feb 19. Mol Microbiol. 2024. PMID: 38372181
-
Microbial communities in the Dead Sea and their potential biotechnological applications.Commun Integr Biol. 2024 Jun 23;17(1):2369782. doi: 10.1080/19420889.2024.2369782. eCollection 2024. Commun Integr Biol. 2024. PMID: 38919836 Free PMC article. Review.
-
More Than Pigments: The Potential of Astaxanthin and Bacterioruberin-Based Nanomedicines.Pharmaceutics. 2023 Jun 26;15(7):1828. doi: 10.3390/pharmaceutics15071828. Pharmaceutics. 2023. PMID: 37514016 Free PMC article. Review.
-
Archaeosomes for Oral Drug Delivery: From Continuous Microfluidics Production to Powdered Formulations.Pharmaceutics. 2024 May 23;16(6):694. doi: 10.3390/pharmaceutics16060694. Pharmaceutics. 2024. PMID: 38931818 Free PMC article.
-
Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent.Beilstein J Nanotechnol. 2024 May 13;15:517-534. doi: 10.3762/bjnano.15.46. eCollection 2024. Beilstein J Nanotechnol. 2024. PMID: 38774586 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous